Cannabiscientia - Scientia potentia est!

[...] In Principles of Clinical Cannabinology, Cannabiscientia provides a comprehensive and easy-to-read guide to the clinical use of cannabis, covering its history, pharmacology, therapeutic applications, and potential benefits and drawbacks. They have in mind as readers healthcare professionals, students, researchers, and patients who seek to understand the science behind cannabis based medicine and its possible roles in treating a wide range of medical conditions. The book is organized in several chapters, each followed by a useful list of references to primary articles and reviews. Throughout the book, the authors draw on the latest scientific research and extensively on anecdotal evidence to present a view of cannabis that strives to be both balanced and objective. There is much still to learn about this complex plant, but this clear and well-written book will serve as a valuable resource for those seeking to understand it better. [...] Read the full foreword »

Scientific findings

The latest scientific discoveries on the pharmacology of phytocannabinoids and other compounds in the cannabis plant have been incorporated, along with the introduction of the innovative concept of Neuro-Gastro-Cannabinology.

Insights on new Countries

Chapter four has been expanded to include the growing acceptance of Medical Cannabis in additional Countries such as France, Slovenia, Spain, and Greece.

Clinical applications

Newly recognised conditions responsive to medical cannabis treatment have been included, along with fresh clinical cases and treatment examples from healthcare professionals prescribing cannabis worldwide.

Products supply

This edition includes an updated overview of currently available medical cannabis products across Europe, with detailed insights into their compositions, titrations, formats (oils, inflorescences, extracts), and pricing. Clinicians will find practical tools to align therapeutic needs with product characteristics, and to navigate availability, formulation selection, and pharmacy sourcing with greater confidence.

Chapter 1: Physiology of the Endocannabinoid System

1.1. Introduction to the Endocannabinoid System
1.2. The Role of the Endocannabinoid System in Pain Management
1.3. The Endocannabinoid System in Sexual Function and Childbirth
1.4. The Endocannabinoid System and the Sleep-Wake Cycle: Implication for Insomnia
1.5. The Endocannabinoid System in the Gastrointestinal Tract
1.6. Neuro-Gastro-Cannabinology
1.7. Insight: Palmitoylethanolamide (PEA): An Overview
1.8. Insight: Homeostasis, Resilience and the Endocannabinoid System
1.9. Insight: The Endocannabinoid System and Stress-Related Anxiety

Chapter 2: Pharmacology of Cannabis and Cannabinoids

2.1. Introduction to Medical Cannabis
2.2. Delivery Methods and Pharmacokinetics of Medical Cannabis
2.3. Pharmacology of Tetrahydrocannabinol (THC)
- 2.3.1. Separating THC’s Therapeutic Effects from the Side Effects
2.4. Pharmacology of Cannabidiol (CBD)
2.5. Pharmacology of Minor Phytocannabinoids
- 2.5.1. Cannabigerol (CBG)
- 2.5.2. Tetrahydrocannabivarin (THCV)
- 2.5.3. Cannabidivarin (CBDV)
2.6. Terpenes and Flavonoids
2.7. Exploring Four New Phytocannabinoids in Cannabis
2.8. Understanding Delta-8-THC and Delta-10-THC
2.9. Insight: The Link between Tryptophan and Cannabis

Chapter 3: Medical Cannabis in Clinical Practice

3.1. Pain and Other Pathologies for which Cannabis
Has Shown Therapeutic Efficacy
- 3.1.1. Case Studies: Fibromyalgia
- 3.1.2. Case Studies: Chronic Pain in Adult Patients
- 3.1.3. Case Studies: Chronic Pain in Elderly Patients
3.2. Cannabis Treatment in Neurological and Neurodegenerative Diseases
- 3.2.1. Cannabis for Parkinson’s Disease
- 3.2.2. Case Study: Parkinson’s Disease
- 3.2.3. Cannabis for Alzheimer’s and Dementia: A Clinical Protocol
- 3.2.4. Cannabis, CBD and Epilepsy
- 3.2.5. Case Study: Drug-Resistant Epilepsy in Adults
- 3.2.6. Cannabis for Multiple Sclerosis
- 3.2.7. Case Study: Multiple Sclerosis
3.3. Cannabis Therapy for Musculoskeletal Disorders
- 3.3.1. Cannabinoids and Musculoskeletal Health
- 3.3.2. Cannabis for Muscular Dystrophy
- 3.3.3. CBD for Temporomandibular Pain
- 3.3.4. CBD Treatment for Low Back Pain
- 3.3.5. Cannabis Use in Sports Medicine
3.4. Cannabis and Cardiovascular Disorders
- 3.4.1. Cannabis in Cardiovascular Diseases
- 3.4.2. Cannabis and Hypertension in Elderly Patients
- 3.4.3. Cannabidiol for Infant Ischemia
3.5. Cannabis Therapy for Metabolic Disorders
- 3.5.1. Medical Cannabis in Diabetes Management
- 3.5.2. Cannabis and Obesity: The Role of THCA
3.6. Dermatological Diseases and the Endocannabinoid System
- 3.6.1. Case Studies: Cannabinoids in Dermatology
3.7. Cannabis Treatment for Inflammatory Bowel Disease (IBD)
- 3.7.1. Case Study: Crohn's Disease
3.8. Neuropsychiatric Applications of CBD
- 3.8.1. Cannabis and CBD for Post-Traumatic Stress Disorder (PTSD)
- 3.8.2. Rationale for the Use of CBD for Autism
  and two Case Studies from Brazil
- 3.8.3. Case Studies: CBD for Autism Spectrum Disorders
- 3.8.4. Hands-on Experience:
  CBD in Attention Deficit Hyperactivity Disorder (ADHD)
- 3.8.5. Case Studies: Autism and ADHD
3.9. Cannabis for Glaucoma
3.10. Cannabis-Based Mouthwashes
3.11. Medical Cannabis in Palliative Care
- 3.11.1. Efficacy and Tolerability of Sativex® in Glioblastoma Patients
- 3.11.2. Case Study: Breast Cancer and Related Comorbidities
- 3.11.3. Case Study: Esophageal Cancer
3.12. Cannabis in the Treatment of Migraine
- 3.12.1. Case Study: Cluster Headaches
3.13. The Impact of Cannabis and Cannabinoids on Sleep and Insomnia
- 3.13.1. Case Study: Chronic Insomnia
3.14. Drug Interactions with Cannabinoids
3.15. Insight: Cannabis and Cannabigerol (CBG)
against Antibiotic Resistance
3.16. Insight: Cannabis Use, Data from an American Study
3.17. Insight: THC in the Treatment
of Acute Respiratory Distress Syndrome (ARDS)

Chapter 4: Medical Cannabis Regulations, Access and Products in Europe

4.1. Foreword by Prohibition Partners
4.2. Medical Cannabis Regulation in Belgium
4.3. Medical Cannabis Regulation in the Czech Republic
4.4. Medical Cannabis Regulation in Denmark
4.5. Medical Cannabis Regulation in France
4.6. Medical Cannabis Regulation in Germany
4.7. Medical Cannabis Regulation in Greece
4.8. Medical Cannabis Regulation in Ireland
4.9. Medical Cannabis Regulation in Italy
4.10. Medical Cannabis Regulation in Malta
4.11. Medical Cannabis Regulation in the Netherlands
4.12. Medical Cannabis Regulation in Poland
4.13. Medical Cannabis Regulation in Portugal
4.14. Medical Cannabis Regulation in Spain
4.15. Medical Cannabis Regulation in Sweden
4.16. Medical Cannabis Regulation in Switzerland
4.17. Medical Cannabis Regulation in the UK
4.18. Medical Cannabis Regulation: Smaller Markets
- 4.18.1. Austria
- 4.18.2. Croatia
- 4.18.3. Finland
- 4.18.4. Lithuania
- 4.18.5. Luxembourg
- 4.18.6. North Macedonia
- 4.18.7. Norway
- 4.18.8. Slovenia